Search results
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 21 hours agoFood and Drug Administration (FDA) on an expedient, repeatable immunobridging pathway to future potential emergency use authorizations (EUAs) for serial, novel monoclonal ...
Antibodies may aid effort to fight influenza B: st | Newswise
Newswise· 1 day agoResearchers at Vanderbilt University Medical Center have isolated human monoclonal antibodies against influenza B, a significant public health threat that disproportionately ...
Monoclonal Antibody May Benefit Patients With Kidney Transplant Rejection
MedPage Today· 4 days agoOriginally developed for multiple myeloma, felzartamab is a fully human IgG1 monoclonal CD38 ...
Researchers take step toward development of universal COVID-19 antibodies
Temple Daily Telegram· 2 days ago"This antibody worked against the original SARS-CoV-2 strain, Omicron and SARS-CoV, providing strong...
U.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND...
The Pendulum· 1 day ago...Drug Administration (FDA) has acknowledged the company's resubmission of the Biologics License Application (BLA) for zolbetuximab, a first-in-class investigational claudin (CLDN) 18.2-targeted monoclonal antibody, for the first-line treatment of adults with locally advanced unresectable or...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 1 day agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
Invivyd aligns with FDA on rapid mAb trial pathway By Investing.com
Investing.com· 15 hours ago(NASDAQ: IVVD), a biopharmaceutical company, has announced an agreement with the U.S. Food and Drug...
Snaking Towards Synthetic Antivenoms
The Scientist· 1 day agoSnakebite envenoming kills more than 100,000 people each year and leaves many more with permanent disabilities.1 Antivenoms based on animal-derived...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 4 days agoGlycoNex and PrecisemAb Sign Technology Licensing Agreement to Advance Development of Novel Anti-Glycan Antibodies for Cancer Therapy PR Newswire NEW TAIPEI CITY, Taiwan, May 28, 2024 GlycoNex ...
Invivyd appoints new Chief Commercial Officer ahead of PEMGARDA launch By Investing.com
Investing.com· 16 hours agoInvivyd, Inc. (NASDAQ:IVVD), a company focused on developing treatments for viral infectious...
